Interleukin-33 Expression on Treatment Outcomes and Prognosis in Brazilian Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Interleukin-33 Expression on Treatment Outcomes and Prognosis in Brazilian Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Interleukin-33 (IL-33), a member of the interleukin-1(IL-1) family of cytokines, remains poorly understood in the context of human breast cancer and its impact on treatment outcomes. This study aimed to elucidate IL-33 expression patterns within tumor samples from a cohort of Brazilian female breast...

Full description

Bibliographic Details
Main Authors: Renata B. Albuquerque, Maria Amélia S. M. Borba, Matheus S. S. Fernandes, Tayrine O. Filgueira, Danyelly Bruneska G. Martins, José Luiz L. Filho, Angela Castoldi, Fabrício Oliveira Souto
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:International Journal of Molecular Sciences
Subjects:
interleukin-33
breast cancer
luminal subtype
Online Access:https://www.mdpi.com/1422-0067/24/22/16326

Similar Items

Similar Items